Contribution: Industrial Research Assistance Program – Contributions to Firms
Avivo Biomedical Inc.
$170,819.00
Assay method development for enzyme activity, characterization and stability testing
FY 2022-23 · 2022-09-06
Summary
This project will involve the development of assay systems to test for and assess enzyme quality, purity and stability, as well as support for the development of monoclonal antibodies (for detection of both enzymes, EnzAO1 and EnzAO2) and preparation of technology transfer datasheets.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
706842473
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2022-09-06 | 2022-23 | $186,000.00 |
| 2 | 2022-09-06 | 2022-23 | $170,819.00 |
As published
Additional Information
This agreement has been amended 2 time(s). The total amended value is -15,181 dollars.
Additional Information (French)
Cet accord a été modifié 2 fois La valeur totale des modifications est de - 15 181 dollars.
Agreement End Date
2023-04-28
Agreement Number
996471
Agreement Start Date
2022-09-06
Agreement Title
Assay method development for enzyme activity, characterization and stability testing
Agreement Title (French)
Développement de méthodes d’essai pour l’activité, la caractérisation et la stabilité des enzymes
Agreement Type
Contribution
Agreement Value
$170,819.00
Amendment Date
2023-03-01
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project will involve the development of assay systems to test for and assess enzyme quality, purity and stability, as well as support for the development of monoclonal antibodies (for detection of both enzymes, EnzAO1 and EnzAO2) and preparation of technology transfer datasheets.
Description (French)
Ce projet comprendra le développement de systèmes de dosage pour tester et évaluer la qualité, la pureté et la stabilité des enzymes, ainsi qu’un soutien au développement d’anticorps monoclonaux (pour la détection des deux enzymes, EnzAO1 et EnzAO2) et la préparation de fiches de transfert de technologie.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Centre
Federal Riding (French)
Vancouver-Centre
Federal Riding Number
59034
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
706842473
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Avivo Biomedical Inc.
Recipient Postal Code
V7X 1L3
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2022-2023-Q3-996471
